New antibiotic in mushroom that grows on horse dung

November 7, 2014
The scientists isolated the new active compound from the grey shag that grows on horse dung. (Photo: Andreas Gminder / / CC BY-NC-SA 3) The scientists isolated the new active compound from the grey shag that grows on horse dung. Credit: Andreas Gminder / / CC BY-NC-SA 3

Researchers from the Institute of Microbiology at ETH Zurich have discovered a new protein with antibiotic properties in a mushroom that grows on horse dung. Researchers are now exploring the various potential applications.

Microbiologists and molecular biologists at ETH Zurich and the University of Bonn have discovered a new agent in fungi that kills . The substance, known as copsin, has the same effect as traditional antibiotics, but belongs to a different class of biochemical substances. Copsin is a protein, whereas traditional antibiotics are often non-protein organic compounds.

The researchers led by Markus Aebi, Professor of Mycology, discovered the substance in the common inky cap mushroom Coprinopsis cinerea that grows on horse dung. When they began their research, the scientists were interested in understanding how this fungus and various bacteria affect each other's growth. This involved cultivating the fungus in a laboratory along with several different types of bacteria. It was found that C. cinerea is able to kill certain bacteria. Further research demonstrated that the copsin produced by the mushroom is responsible for this antibiotic effect.

Copsin belongs to the group of defensins, a class of small proteins produced by many organisms to combat microorganisms that cause disease. The human body also produces defensins to protect itself against infections. They have been found, for example, on the skin and in the mucous membranes.

A question for basic research

For Aebi, the main focus of this research project was not primarily on applications for the new substance. "Whether copsin will one day be used as an antibiotic in medicine remains to be seen. This is by no means certain, but it cannot be ruled out either," he says.

The ETH professor is much more intrigued by fundamental questions, such as how fungi have used defensins and other naturally for millions of years to protect themselves against bacteria. Why does this work for fungi while humans have been using antibiotics in medicine for just 70 years with many of them already becoming useless due to resistance? "Fungi have internal instructions on how to use these substances without resulting in selection of resistant bacteria. How to decode these instructions is an intriguing problem for basic research," explains Aebi.

The three-dimensional structure studied by ETH researchers exhibits the compact form of copsin. (Source: Essig A et al. JBC 2014 The three-dimensional structure studied by ETH researchers exhibits the compact form of copsin. Credit: Essig A et al. JBC 2014

An extremely stable protein

Andreas Essig, a postdoc in Aebi's group and lead author of the study, is currently exploring potential for copsin that has been registered for patent approval. It was the biochemical properties of the substance that led the scientist to do so. "Copsin is an exceptionally stable protein," says Essig. Proteins are generally susceptible to protein-degrading enzymes and high temperatures. Copsin is an exception because it also remains stable when heated to a temperature of 100 degrees Celsius for several hours or when subjected to protein-degrading enzymes. The researchers believe that the has these properties because of its extremely compact three-dimensional structure, as NMR spectroscopy has shown.

The ETH researchers were also able to unravel the exact mechanism of action, discovering that copsin can bind to lipid II, an essential building block for the of bacteria. "Building the cell wall is the Achilles heel of bacteria," explains Essig. If copsin binds to lipid II, the bacteria die because they are unable to build new cell wall.

In addition to being used as an antibiotic in medicine, it may also be possible to use copsin in the food industry as well. This is because copsin kills many pathogens including Listeria, a type of bacteria that can cause severe food poisoning and is therefore feared, especially in the production of non-heat treated foodstuffs such as raw milk cheeses and dried meats.

Explore further: Mycotoxin protects against nematodes

More information: Essig A, Hofmann D, Münch D, Gayathri S, Künzler M, Kallio PT, Sahl HG, Wider G, Schneider T, Aebi M: Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. Journal of Biological Chemistry, online publication 23 October 2014, DOI: 10.1074/jbc.M114.599878

Related Stories

Mycotoxin protects against nematodes

May 27, 2014

Researchers at ETH Zurich have isolated a protein from a fungus of the spruce which combats nematodes. The scientists hope that toxins of this kind will become the basis for the vaccination of livestock or domestic animals ...

Bio researchers receive patent to fight superbugs

October 7, 2014

Superbugs, antibiotic-resistant bacteria, have been on the rise since antibiotics were first introduced 80 years ago. That's because these germ-fighting agents have lost their punch from being overprescribed and misused, ...

New weapon against highly resistant microbes within grasp

May 27, 2010

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria. ...

Making sure antibiotics work as they should

October 8, 2014

Researchers at ETH Zurich are decoding the structure of the large ribosomal subunit of the mitochondria at an atomic level, thereby providing insight into the molecular architecture of this ribosome with implications for ...

Bacteria from bees possible alternative to antibiotics

September 8, 2014

Raw honey has been used against infections for millennia, before honey - as we now know it - was manufactured and sold in stores. So what is the key to its' antimicrobial properties? Researchers at Lund University in Sweden ...

New approach for tuberculosis drugs

July 2, 2014

In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed. Current treatments increasingly fail due to multidrug-resistant pathogens. ETH researchers ...

Recommended for you

A composite thread that varies in rigidity

October 27, 2016

EPFL scientists have developed a new type of composite thread that varies in stiffness depending on its temperature. Applications range from multifunctional robots to knitted casts, and even tunable medical devices.

Turning CO2 to stone

October 25, 2016

Earth has limits to the amount of carbon dioxide in its atmosphere before the environment as we know it starts to change. Too much CO2 absorbed by the oceans makes the water more acidic. Too much in the atmosphere warms the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.